Classification and recent advances in idiopathic interstitial pneumonia

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 5, 1998, Pages 256-260

  Nagai, Sonoko ^a   Kitaichi, Masanori ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHRONIC DISEASE; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; GRANULATION TISSUE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG FIBROSIS; LUNG LAVAGE; PATHOLOGY; PROGNOSIS; REVIEW;

ACUTE DISEASE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; GRANULATION TISSUE; HUMANS; LUNG DISEASES, INTERSTITIAL; PROGNOSIS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032148990     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199809000-00003     Document Type: Article

References (29)

1. Liebow AA: Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975, 8:1-33.
2. Katzenstein AL: Idiopathic interstitial pneumonia. In Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. Vol 13 in the series Major Problems in Pathology, edn. 3. Edited by Livolsi VA. Philadelphia: W.B. Saunders Company; 1997:48-80. Pathological descriptions based on pathophysiologic comprehension of lung njuries are summarized in this book.
3. Nagai S, Izumi T: Bronchiolitis obliterans organizing pneumonia. Curr Opin Pulm Med 1996, 2:419-423.
4. Kitaichi M: Desquamative interstitial pneumonia: an idiopathic interstitial pneumonia with a possibility of spontaneous regression. Intern Med 1997, 36:672-673.
5. Colby TV, Lombard CL, Yousem SA, Kitaichi M: Interstitial diseases. In Atlas of Pulmonary Surgical Pathology. Edited by Bordin GM. Philadelphia: WB Saunders; 1991:228-306.
6. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV: Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. Eur Respir J 1998, in press.
7. Travis WD, Fox CH, Devaney KO, Weiss LM, O'Leary TJ, Ognibene FP, et al.: Lymphoid pneumonias in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonias. Hum Pathol 1992, 23:529-541.
8. Sattler F, Nichols L, Hirano L, Hiti A, Hofman F, Hughlett C, et al.: Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1997, 156:912-917.
9. Rubino C, Hill ME, Milan S, O'Brien MER, Cunningham D: Idiopathic pneumonia syndrome after high dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer 1997, 75:1044-1048.
10. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199-203. In this pathological rereview of 104 patients with IPF, a heterogeneous group comprising patients with UIP, DIP. NSIP, AIP, BOOP, and others was included. Patients with UIP had worse survival than patients with idiopathic NSIP.
11. Nagai S, Izumi T: Immunopathology of collagen vascular disease. Curr Opin Pulm Med 1997, 3:356-360. In this review, a heterogeneity of interstitial pneumonia associated with collagen vascular diseases was categorized and compared with heterogeneities in IIP, based on the histopathology and bronchoalveolar lavage cell findings.
12. Hamman L, Rich A: Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935, 51:154-163.
13. Olson J, Colby TV, Elliott CG: Hamman-Rich syndrome revisited. Mayo Clin Proc 1990, 65:1538-1548.
14. Meduri GU: The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlation and response to gluco-corticoid treatment. Eur Respir J 1996, 9:2650-2670.
15. Ichikado K, Johkoh T, Ikezoe J, Takeuchi N, Kohno N, Arisawa J, et al.: Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. AJR Am J Roentgenol 1997, 168:333-338.
16. Yousem SA, Lohr RH, Colby TV: Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 1997, 10:864-871.
17. Lohr RH, Boland BJ, Douglas WW, Dockrell DH, Colby TV, Swensen SJ, et al.: Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997, 157:1323-1329. Based on a sizable number of patients with OP, the author clarified a difference in prognosis between idiopathic and secondary OP.
18. Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E: Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997, 52:333-337. Using serial HRCT examination in patients with DIP, the authors concluded that there was no transfer from DIP to UIP.
19. Matsuo K, Tada S, Kataoka M, Okahara M, Hiramatsu J, Horiba M, et al.: Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997, 36:728-731.
20. Nagai S, Izumi T: Bronchoalveolar lavage: still useful in diagnosing sarcoidosis? Clin Chest Med 1997, 18:787-797. Interstitial lung diseases can be categorized using bronchoalveolar lavage fluid cell pattern, and this categorization is compatible with their histopathology and clinical courses.
21. MacAdams HP, Rosado de Christenson ML, Wehunt WD, Fishback NF: The alphabet soup revisited: the chronic interstitial pneumonias in the 1990s. Radiographics 1996, 16:1009-1033.
22. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S: CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997, 168:79-83. The finding of significant opacities that suggest acute exacerbation of IPF on HRCT may be useful for the treatment of patients with IPF.
23. Nagata N, Nagatomo H, Yoshii C, Nikaido Y, Kido M: Features of idiopathic pulmonary fibrosis with organizing pneumonia. Respiration 1997, 64:331-335.
24. Hubbard R, Johnston I, Coultas DB, Britton J: Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996, 51:711-716.
25. Mahhino DM, Etzel RA, Parrish RG: Pulmonary fibrosis deaths in the United States, 1979-1991: an analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996, 153:1548-1552.
26. Hunninghake GW, Kalica AR: Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995, 151:915-918.
27. Raghu G: Idiopathic pulmonary fibrosis: a need for treatment with drugs other than corlicosteroids. A role for antifibrotic agents? Mayo Clin Proc 1997, 72:285-287.
28. Douglas WW, Ryu JH, Bjoraker JA, Schroeder DR, Myer JL, Tazelaar HD, et al.: Colchicine versus predonisone as treatment of usual interstitial pneumonia. Mayo Clin Proc 1997, 72:201-209.
29. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ: Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998, 351:24-27.